Search Results - "Jeddi, Ramzi"
-
1
Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia
Published in Hematology (Luxembourg) (01-01-2012)“…Cytogenetic data are essential not only for the diagnosis of acute myeloid leukemia but also for the evaluation of prognosis. Large systematic studies of…”
Get more information
Journal Article -
2
Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia
Published in Medical oncology (Northwood, London, England) (01-03-2011)“…Differentiation syndrome (DS) is a life-threatening complication observed in patients with acute promyelocytic leukemia (APL) receiving induction therapy with…”
Get full text
Journal Article -
3
A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13
Published in Annals of hematology (01-08-2008)“…Hereditary thrombotic thrombocytopenic purpura (TTP) is a rare disorder characterized by occlusive microvascular thrombosis, consumptive thrombocytopenia, and…”
Get full text
Journal Article -
4
Isolated extramedullary relapse in the breast of a patient with acute myeloid leukemia following allogeneic stem cell transplantation : Case report and review of the literature
Published in International journal of hematology (01-02-2007)“…We report an unsual case of a woman with acute myeloid leukemia who showed an isolated extramedullary relapse (IEMR) in the breast following allogeneic stem…”
Get full text
Journal Article -
5
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
Published in Mediterranean journal of hematology and infectious diseases (08-09-2011)“…In Tunisia, the ATRA era began in 1998 with the use, consecutively, of two regimens combining ATRA and an anthracycline with cytarabine (APL93), and without…”
Get full text
Journal Article -
6
Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial
Published in Blood (15-02-2008)“…From April 2003 to December 2006, 195 patients with de novo symptomatic myeloma and younger than 60 years of age were randomly assigned to receive either…”
Get full text
Journal Article -
7
Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)
Published in Blood (03-12-2015)“…Background: Hypomethylating agents, especially AZA, have become the reference treatment of higher risk MDS, but the median survival of about 2 years obtained…”
Get full text
Journal Article -
8
High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia
Published in Leukemia research (01-04-2010)“…Abstract Increased BMI has been correlated to an increased incidence of APL, but not to the occurrence of differentiation syndrome (DS) in APL. We…”
Get full text
Journal Article -
9
Azacitidine (AZA) Combined with Idarubicin in Untreated Patients with High Risk MDS – Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies
Published in Blood (16-11-2012)“…Abstract 1720 hypomethylating agents, especially AZA, have become the reference treatment of higher risk MDS, but the median survival of about 2 years obtained…”
Get full text
Journal Article -
10
Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience
Published in Blood (16-11-2012)“…Abstract 4297 In Tunisia children with acute lymphoblastic leukemia (ALL) are treated according to the EORTC 58951 protocol with complete remission rate (CR)…”
Get full text
Journal Article -
11
Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes
Published in Hematology (Luxembourg) (01-02-2010)“…Severe sepsis defined as infection-induced organ dysfunction or hypoperfusion abnormalities predispose to septic shock and increased mortality in neutropenic…”
Get more information
Journal Article -
12
Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?
Published in Blood (18-11-2011)“…Abstract 4271 In Tunisia, before 1998, ATRA was not available in APL, and we reported CR rates of 37.5% (unpublished results). The ATRA era began in 1998 with…”
Get full text
Journal Article -
13
ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia
Published in Medical oncology (Northwood, London, England) (01-12-2011)“…Reports on childhood APL from developing countries are scarce. We treated 65 APL with two consecutive trials combining ATRA and chemotherapy. Twenty (30.7%)…”
Get full text
Journal Article -
14
High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL)
Published in Blood (19-11-2010)“…Abstract 1078 High BMI was recently identified as a new predictor of differentiation syndrome (DS) in a relatively small Tunisian series of 39 APL patients…”
Get full text
Journal Article -
15
Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections
Published in Blood (20-11-2009)“…Abstract 4552 Pseudomonas aeruginosa is a leading cause of nosocomial infections usually associated with high mortality. The aim of this study was to determine…”
Get full text
Journal Article -
16
Abdelkefi A, Ladeb S, Torjman L, Ben Othman T, Lakhal A, Ben Romdhane N, El Omri H, Elloumi M, Belaaj H, Jeddi R, Aissaouï L, Ksouri H, Ben Hassen A, Msadek F, Saad A, Hsaïri M, Boukef K, Amouri A, Louzir H, Dellagi K, Ben Abdeladhim A, on behalf of the Tunisian Multiple Myeloma Study Group. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical
Published in Blood (11-06-2009)Get full text
Journal Article -
17
Immunophenotyping in adult acute myeloid leukemia: which prognostic value?
Published in Tunisie Medicale (01-08-2012)“…Immunophenotyping is an essential step in the diagnosis of acute myeloid leukemia. Its prognostic value remains controversial with contradictory results. To…”
Get more information
Journal Article -
18
Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections
Published in Hematology (Luxembourg) (01-05-2011)“…Pseudomonas is a clinically significant and opportunist pathogen, usually associated in causing high mortality nosocomial infections. The aim of this study was…”
Get more information
Journal Article -
19
Predictive factors of septic shock and mortality in neutropenic patients
Published in Hematology (Luxembourg) (01-12-2007)“…Neutropenia is a major risk factor for developing a serious infection. Bacteremia still causes significant mortality among neutropenic patients with cancer…”
Get more information
Journal Article -
20
Predictive Factors of All Trans-Retinoic Acid (ATRA) Related Complications during Induction Course of Acute Promyelocytic Leukemia (APL)
Published in Blood (16-11-2006)“…Background: The combination of ATRA and chemotherapy has made APL a highly curable leukemia. However several complications are reported with this treatement…”
Get full text
Journal Article